Proton Partners
International have signed agreement with University of Liverpool

THE University of Liverpool have signed
a 2 year collaborative research project with Proton Partners International Ltd,
to enhance proton beam therapy technology.

This signing, that took place on 13 April
2017, will now see the 2 partners developing a new measurement system, known as
a 3D Water Phantom, which will further improve the accuracy of proton beam
therapy treatment.

The new system will use pixelated silicon
detectors, 1st developed at CERN, the European Organisation for Nuclear
Research. Improved accuracy will lead to better modelling and calibration of
treatment beams which will offer more advanced treatment for patients. It will
also allow for more accurate clinical research and development to be undertaken.

Proton Partners International is building a series of Oncology Centres, known
as:- 'The Rutherford Cancer Centres,'which will offer:- proton
beam therapy, radiotherapy, chemotherapy, imaging and wellbeing services. The
company's 1st centre in Newport, South Wales, will be the 1st in the UK to offer
proton beam therapy.

Proton Parents
International is also building a Cancer Centre in Knowledge Quarter Liverpool's
Paddington Village. Further centres are currently being built in Northumberland
and Reading.

Professor Anthony Hollander, Associate Pro Vice Chancellor, for
enterprise, at The University of Liverpool, said:- "We are delighted to be
working with the UK's leaders in proton beam therapy to develop a new commercial
system to improve proton beam therapy delivery. Liverpool will be home to 1 of
the few Proton Beam Therapy Centres in the UK, thanks to Proton Partners
International, and by working together we will ensure that Liverpool becomes 1
of the world leaders in proton beam therapy research."

Dr Ian Barwick, Chief Scientific Officer of Proton Partners International,
said:- "Whilst we are building Cancer Centres across the country, we have
always said that research and development are key to our work as we look ahead.
By creating this new system, we will be making an important and innovative step
in improving how proton beam therapy is actually delivered to patients. Our
partnership with The University of Liverpool demonstrates that we are completely
committed to improving proton beam therapy technology and advancing the wider
research effort in cancer care."

Proton Partners International has also signed a 10 year lease to establish a
genomics research centre at the Life Sciences Accelerator building in Liverpool,
which is due to open later in 2017. The Proton Partners International genomics
programme will collate, analyse and distribute data from its treatment centres
which will support its broader research work with The University of Liverpool's
Physics Department.

The building is the 1st part of a 'health campus' that is set to
surround the ₤335m new Royal Liverpool Hospital. The lease is with The Royal and
Liverpool Broadgreen University Hospitals NHS Trust.

Read this page.
Sorry your browser does not support the audio element on this page.